Involvement of integrin αV gene expression in human melanoma tumorigenicity
FELDING-HABERMANN, B, MUELLER, B. M, ROMERDAHL, C. A, CHERESH, D. A
Published in The Journal of clinical investigation (01.06.1992)
Published in The Journal of clinical investigation (01.06.1992)
Get full text
Journal Article
Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity
BOUSQUET, P. F, BRANA, M. F, KEILHAUER, G, ROMERDAHL, C. A, CONLON, D, FITZGERALD, K. M, PERRON, D, COCCHIARO, C, MILLER, R, MORAN, M, GEORGE, J, XIAO-DONG QIAN
Published in Cancer research (Chicago, Ill.) (01.03.1995)
Get full text
Published in Cancer research (Chicago, Ill.) (01.03.1995)
Journal Article
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody
Mueller, BM, Romerdahl, CA, Gillies, SD, Reisfeld, RA
Published in The Journal of immunology (1950) (15.02.1990)
Published in The Journal of immunology (1950) (15.02.1990)
Get full text
Journal Article
Bis-naphthalimides 3: synthesis and antitumor activity of N,N'-bis[2-(1,8-naphthalimido)-ethyl] alkanediamines
Braña, M F, Castellano, J M, Morán, M, Pérez de Vega, M J, Perron, D, Conlon, D, Bousquet, P F, Romerdahl, C A, Robinson, S P
Published in Anti-cancer drug design (01.06.1996)
Get more information
Published in Anti-cancer drug design (01.06.1996)
Journal Article